P2RX7 and neoplasm: Importantly, the anti-tumor protection conferred by early ferroptotic cells depended on ATP-Purinergic Receptor P2X7 signaling, as blockade with oxidized-ATP abolished this effect, highlighting how DCs process and present tumor antigens via MHC complexes to activate T cells (41).